* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (MEX:TAK N) has a OCF Margin % of 6.81% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Takeda Pharmaceutical Co and its competitors. This is 69% below median its historical median of 22.21. Over the past decade, Takeda Pharmaceutical Co's OCF Margin % has ranged from 15.09 to 31.61. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #161 out of 959 companies in the Drug Manufacturers industry, placing it in the top 16.8%.
Is Takeda Pharmaceutical Co's OCF Margin % too high?
Takeda Pharmaceutical Co's current OCF Margin % of 6.81% is 69% below median its 10-year median of 22.21. Over the past 10 years, this metric has ranged from a low of 15.09 to a high of 31.61. The Drug Manufacturers industry median OCF Margin % is 9.95. Takeda Pharmaceutical Co's value of 6.81% is 31.6% below this industry median. Based on the distribution chart, Takeda Pharmaceutical Co ranks #161 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #161 out of 959 companies for OCF Margin %. This places Takeda Pharmaceutical Co in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Takeda Pharmaceutical Co's value of 6.81% is 31.6% below this benchmark. Historically, Takeda Pharmaceutical Co's own OCF Margin % has ranged from 15.09 to 31.61 over the past decade. While the company's 10-year median is 22.21 vs. the industry median of 9.95, Takeda Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takeda Pharmaceutical Co's current OCF Margin % of 6.81% is 31.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current OCF Margin % is 6.81%, which is 69% below median its own 10-year median of 22.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Takeda Pharmaceutical Co (MEX:TAK N) has a current OCF Margin % of 6.81%. The stock's GF Value™ is MXN289.17, compared to a current price of MXN320.00 — trading 10.7% above its estimated fair value. The current OCF Margin % is 6.81%, which is 69% below median its 10-year median of 22.21 and 31.6% below the Drug Manufacturers industry median of 9.95. Takeda Pharmaceutical Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Takeda Pharmaceutical Co (MEX:TAK N), the current OCF Margin % is 6.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (MEX:TAK N) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN320.00 is trading 10.7% above its estimated GF Value™ of MXN289.17.
Key valuation signals for MEX:TAK N:
OCF Margin %: 6.81% (69% below median its 10-year median of 22.21)
GF Value™: MXN289.17 vs. price of MXN320.00 (10.7% above fair value)
Industry Position: 31.6% below the Drug Manufacturers median (#161 of 959)
No single metric tells the full story. See the MEX:TAK N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
67GF Score
Get the complete analysis for MEX:TAK N
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TAK N has been successfully added to your 
